TNXP Tonix Pharmaceutical - es geht los - - 500 Beiträge pro Seite
eröffnet am 11.03.19 12:26:44 von
neuester Beitrag 11.02.21 14:19:30 von
neuester Beitrag 11.02.21 14:19:30 von
Beiträge: 5
ID: 1.299.756
ID: 1.299.756
Aufrufe heute: 0
Gesamt: 689
Gesamt: 689
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 35 Minuten | 1779 | |
heute 14:00 | 1162 | |
vor 1 Stunde | 1110 | |
heute 13:20 | 1089 | |
gestern 18:31 | 962 | |
vor 1 Stunde | 779 | |
vor 47 Minuten | 770 | |
heute 09:07 | 747 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.161,01 | +1,36 | 217 | |||
2. | 3. | 0,1885 | -0,26 | 90 | |||
3. | 2. | 1,1800 | -14,49 | 77 | |||
4. | 5. | 9,3500 | +1,14 | 60 | |||
5. | 4. | 168,29 | -1,11 | 50 | |||
6. | Neu! | 0,4400 | +3,53 | 36 | |||
7. | Neu! | 4,7950 | +6,91 | 34 | |||
8. | Neu! | 11,905 | +14,97 | 31 |
Meiner Meinung nach dürfte es hier gleich nach oben gehen....die Meldung ist noch nicht überall veröffentlicht
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
ByME Staff 8-k -
March 11, 2019
Share on Facebook Tweet on Twitter
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
Item 7.01.
Regulation FD.
Story continues below
Tonix Pharmaceuticals Holding Corp. (the “Company”) announced today that the first participant was enrolled in the “RECOVERY” Study, a new phase 3 trial for the Company’s lead product candidate, Tonmya (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the treatment of posttraumatic stress disorder. A copy of the press release announcing this matter is furnished as Exhibit 99.01.
The information in this Item 7.01 of this Current Report on Form8-K, including Exhibit99.01 attached hereto, shall not be deemed “filed” for purposes of Section18 of the United States Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the United States Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01.
Financial Statements and Exhibits.
(d)
ExhibitNo.
Description.
99.01
Press Release, dated March 11, 2019
Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE Tonix Pharmaceuticals Holding Corp. 8-K Exhibit 99.1 Tonix Pharmaceuticals Enrolls First Participant in the “RECOVERY” Study — a New Phase 3 Trial of Tonmya® for the Treatment of Posttraumatic Stress Disorder Topline Data Expected First Half 2020 NEW YORK,…
To view the full exhibit click here
An ad to help with our costs
TAGS
8-K
SEC Filings
TNXP
Tonix Pharmaceuticals Holding Corp.
SHARE Facebook Twitter
RELATED ARTICLESMORE FROM AUTHOR
MEDIFIRST SOLUTIONS, INC (OTCMKTS:MFST) Files An 8-K Unregistered Sales of Equity Securities
TRANSOCEAN LTD. (NYSE:RIG) Files An 8-K Regulation FD Disclosure
Ensco plc (NYSE:ESV) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure
SUPER MICRO COMPUTER, INC. (NASDAQ:SMCI) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
WHIRLPOOL CORPORATION (NYSE:WHR) Files An 8-K Other Events
A word from the sponsor
Promoted Content
All Eyes On Adam Schiff In Wake Of Backfired Leak
bizpacreview.com
British Activist Warns America About Rep. Ilhan Omar
independentsentinel.com
Gorka, Fox Part Ways
thehill.com
Woman Missing For 18 Years Found In Sister's Freezer
newser.com
Teacher Who Had Sex With 6th Grade Student Had Student Lookout
waynedupree.com
First She Ran For Office. Then She Ran A Record Ironman
newser.com
Quotes by TradingView
Latest Articles
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
ByME Staff 8-k -
March 11, 2019
Share on Facebook Tweet on Twitter
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
Item 7.01.
Regulation FD.
Story continues below
Tonix Pharmaceuticals Holding Corp. (the “Company”) announced today that the first participant was enrolled in the “RECOVERY” Study, a new phase 3 trial for the Company’s lead product candidate, Tonmya (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the treatment of posttraumatic stress disorder. A copy of the press release announcing this matter is furnished as Exhibit 99.01.
The information in this Item 7.01 of this Current Report on Form8-K, including Exhibit99.01 attached hereto, shall not be deemed “filed” for purposes of Section18 of the United States Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the United States Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01.
Financial Statements and Exhibits.
(d)
ExhibitNo.
Description.
99.01
Press Release, dated March 11, 2019
Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE Tonix Pharmaceuticals Holding Corp. 8-K Exhibit 99.1 Tonix Pharmaceuticals Enrolls First Participant in the “RECOVERY” Study — a New Phase 3 Trial of Tonmya® for the Treatment of Posttraumatic Stress Disorder Topline Data Expected First Half 2020 NEW YORK,…
To view the full exhibit click here
An ad to help with our costs
TAGS
8-K
SEC Filings
TNXP
Tonix Pharmaceuticals Holding Corp.
SHARE Facebook Twitter
RELATED ARTICLESMORE FROM AUTHOR
MEDIFIRST SOLUTIONS, INC (OTCMKTS:MFST) Files An 8-K Unregistered Sales of Equity Securities
TRANSOCEAN LTD. (NYSE:RIG) Files An 8-K Regulation FD Disclosure
Ensco plc (NYSE:ESV) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure
SUPER MICRO COMPUTER, INC. (NASDAQ:SMCI) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
WHIRLPOOL CORPORATION (NYSE:WHR) Files An 8-K Other Events
A word from the sponsor
Promoted Content
All Eyes On Adam Schiff In Wake Of Backfired Leak
bizpacreview.com
British Activist Warns America About Rep. Ilhan Omar
independentsentinel.com
Gorka, Fox Part Ways
thehill.com
Woman Missing For 18 Years Found In Sister's Freezer
newser.com
Teacher Who Had Sex With 6th Grade Student Had Student Lookout
waynedupree.com
First She Ran For Office. Then She Ran A Record Ironman
newser.com
Quotes by TradingView
Latest Articles
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
Antwort auf Beitrag Nr.: 60.067.752 von Fusselsocke am 11.03.19 12:26:44Gleich gehts weiter nach oben! 3,50 sollten wir übertreffen. Hold for gold
we will see!
da holen sich heute wieder einige eine blutige nase!
BOOOOM:
https://finance.yahoo.com/news/tonix-pharmaceuticals-license…
Sehen wir die 3€ doch schon viel eher als gedacht?
https://finance.yahoo.com/news/tonix-pharmaceuticals-license…
Sehen wir die 3€ doch schon viel eher als gedacht?
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
67 | ||
61 | ||
48 | ||
38 | ||
31 | ||
28 | ||
16 | ||
10 | ||
9 | ||
9 |